|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-5-25
|
|
pubmed:abstractText |
Retinol-binding protein 4 (RBP4) is an adipocyte-derived 'signal' that may contribute to the pathogenesis of insulin resistance and Type 2 diabetes. The relationship of RBP4 with insulin resistance and metabolic risk in human beings has been the subject of several studies. Subjects born small for gestational age (SGA) are at risk of insulin resistance and Type 2 diabetes. Though RBP4 could represent an early marker of insulin resistance, to date, none have determined RBP4 in SGA children.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1720-8386
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
218-21
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20503483-Adiponectin,
pubmed-meshheading:20503483-Adult,
pubmed-meshheading:20503483-Birth Weight,
pubmed-meshheading:20503483-Diabetes Mellitus, Type 2,
pubmed-meshheading:20503483-Female,
pubmed-meshheading:20503483-Gestational Age,
pubmed-meshheading:20503483-Humans,
pubmed-meshheading:20503483-Infant, Newborn,
pubmed-meshheading:20503483-Infant, Small for Gestational Age,
pubmed-meshheading:20503483-Insulin,
pubmed-meshheading:20503483-Insulin Resistance,
pubmed-meshheading:20503483-Male,
pubmed-meshheading:20503483-Retinol-Binding Proteins, Plasma,
pubmed-meshheading:20503483-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Retinol-binding protein 4 in neonates born small for gestational age.
|
|
pubmed:affiliation |
Molecular Endocrinology Unit, D.P.U.O. Bambino Gesù Children's Hospital, Rina Balducci Center of Pediatric Endocrinology, Tor Vergata University, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article
|
